Rego Katia G. M., Billerbeck Ana Elisa C., Targovnik Hector M., Santos Cecilia L. S., Alkmin Maria G., Barbosa Sonia, Camargo Rosalinda, Medeiros-Neto Geraldo
MD, PhD.
Endocr Pathol. 1997 Spring;8(1):37-47. doi: 10.1007/BF02739706.
Two unrelated families (CA and NA) in which an iodide organification defect (lOD) was present in two siblings of each family were studied. These patients had congenital goiters with hypothyroidism and a positive perchlorate discharge test. Examination of the thyroid tissue revealed no thyroid peroxidase (TPO) activity. Histologic findings were consistent with a microfollicular pattern of hyperplasia. Moderate cellular atypia was present, characterized by nuclear pleomorphism and hyperchromatism. Full length thyroglobulin was purified by gel filtration, but was not iodinated. Immunohistochemical studies using a polyclonal anti-human thyroid peroxidase (hTPO) antibody confirmed the presence of immunoreactive TPO protein in the thyroid tissues. Samples of normal and affected individuals were studied with respect to the presence of various fragments using TPO probes of varying sizes. The two affected siblings from family CA were homozygous for fragments 3.9, 4.6, and 7.0 kb (8g111) and 2.3 and 2.9 kb (Ta ql), whereas the parents were heterozygous. In the other family (NA), the Bg/ll digestion and TPO-31 hybridization revealed an interesting and informative polymorphism. The parents showed two different polymorphic patterns: the father had a 5.0/4.6 kb pattern and the mother a 4.7/4.5 kb pattern. However, the two affected siblings showed the same heterozygotic allelic pattern at 4.5/4.6 kb. The restriction fragment length polymorphism detected in these two families suggests an association between the TPO gene and an lOD. Results suggest that in these dyshormonogenetic tissues an altered TPO protein molecule is being synthesized, without detectable in vitro activity, but visible by immunostaining techniques in the goitrous tissue. Mutations in the TPC gene sequence are most likely associated with these changes.
对两个不相关的家庭(CA和NA)进行了研究,每个家庭的两名兄弟姐妹都存在碘有机化缺陷(IOD)。这些患者患有先天性甲状腺肿并伴有甲状腺功能减退,且过氯酸盐释放试验呈阳性。对甲状腺组织的检查显示没有甲状腺过氧化物酶(TPO)活性。组织学结果与微滤泡增生模式一致。存在中度细胞异型性,其特征为核多形性和核深染。通过凝胶过滤纯化了全长甲状腺球蛋白,但未进行碘化。使用多克隆抗人甲状腺过氧化物酶(hTPO)抗体的免疫组织化学研究证实甲状腺组织中存在免疫反应性TPO蛋白。使用不同大小的TPO探针研究了正常个体和患病个体样本中各种片段的存在情况。来自CA家庭的两名患病兄弟姐妹在3.9、4.6和7.0 kb(Bg111)以及2.3和2.9 kb(Taq1)片段上是纯合子,而父母是杂合子。在另一个家庭(NA)中,Bg/11消化和TPO - 31杂交显示出一种有趣且有信息量的多态性。父母表现出两种不同的多态性模式:父亲具有5.0/4.6 kb模式,母亲具有4.7/4.5 kb模式。然而,两名患病兄弟姐妹在4.5/4.6 kb处表现出相同的杂合等位基因模式。在这两个家庭中检测到的限制性片段长度多态性表明TPO基因与IOD之间存在关联。结果表明,在这些激素合成障碍组织中,正在合成一种改变的TPO蛋白分子,其在体外无活性,但通过免疫染色技术在甲状腺肿组织中可见。TPC基因序列中的突变很可能与这些变化有关。